Clinical trials
Observational Obesity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 9 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Unknown status | 26 |
| Recruiting | 13 |
| Active, not recruiting | 5 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| John Sievenpiper | 12 |
| University of Toronto | 11 |
| Laval University | 7 |
| University of Alberta | 6 |
| The Hospital for Sick Children | 5 |
| University of British Columbia | 4 |
| Université de Sherbrooke | 4 |
| Concordia University, Montreal | 3 |
| Novo Nordisk A/S | 3 |
| University of Manitoba | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 90 |
| Overweight | 25 |
| Body Weight | 23 |
| Diabetes Mellitus | 21 |
| Cardiovascular Diseases | 18 |
| Metabolic Syndrome | 16 |
| Diabetes Mellitus, Type 2 | 15 |
| Hypertension | 13 |
| Prediabetic State | 13 |
| Insulin Resistance | 11 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.